Zomedica Corp. (ZOM) stock prices were up by 3.15% as of the market closing on September 30th 2021. This brought the price per share up to USD$.0.52 at the end of the trading day. Subsequent premarket fluctuations have seen the stock rise by 20.36%, bringing it up to USD$0.63.
ZOM Stock’s Partnership
October 1st 2021 saw ZOM stock announce the acquisition of Pulse Veterinary Technologies. As per the agreement, the transaction amounted to USD$70.9 million and consisted of a mix of cash and stock options. Pulse Veterinary Tech is a world leader in electro-hydraulic shock wave technology. This technology has a broad variety of applications as a treatment of conditions in veterinary patients. The high-energy sound waves stimulate cells and facilitate the release of healing growth factors in the body. These factors reduce inflammation, increase blood flow, and accelerate bone and soft tissue development. The partnering company’s technology is used in conditions including tendon and ligament healing, bone healing, osteoarthritis, chronic pain, and wound healing.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
The partnering company’s business employs a razor-razorblade economic model. According to this model, customers buy a shock wave generator as capital equipment, as well as replaceable therapy hand pieces called Trodes. Each Trode boasts an expected life of forty to fifty therapy sessions. Upon completing the extent of its useful life, Trodes are replaced with a refurbished alternative by customers themselves.
PulseVet is currently the market leader in the equine space, boasting 1,500 systems that are actively in use globally. The partnering company recently launched X-Trode, a new handpiece with an energy output intended for maximum efficacy while circumventing the need for patient sedation. ZOM stock has been continuing to complement its TRUFORMA product platform. This support was in the form of previous fundraising efforts and the establishment of a business development capability.
ZOM Stock’s Trajectory of Success
The company is also allocating resources towards accelerating the growth of ZOM stock overall. This is facilitated with investments in expanding the company’s product offerings, technologies, and product development efforts. Their selective process is focused on the expansion of the company’s capability to network with more veterinary clinic partnerships. This will be facilitated by the provision of novel and valuable offerings that enhance both animal and veterinary practice health.
Future Outlook for ZOM Stock
ZOM stock reported a promising quarter, consolidated by its acquisition of Pulse Veterinary Technologies. The company is keen to spearhead efforts to properly manage the combined resources at its disposal. Current and potential investors are hopeful that this will result in sustained and significant increases in shareholder value.